8-K
filed April 24, 2023, 7:59 PM ET
ticker KBH
CIK 0000795266
other
confidence high
sentiment neutral
materiality 0.15
KB Home shareholders elect all 11 directors, approve all proposals at annual meeting
KB HOME
- All 11 director nominees elected; James C. Weaver received 86.5% for, 13.5% against.
- Say-on-pay advisory vote passed with 80.3% support; board will hold it annually.
- Ratification of Ernst & Young as auditor approved with 97.7% of votes cast.
- Amended 2014 Equity Incentive Plan approved with 94.4% of votes cast.
- Advisory vote on frequency: 93.9% favor annual; board adopts annual frequency.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
KB HOME shareholders approved Non-binding advisory vote to approve named executive officer compensation at the 2023-04-20 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-04-20
Exact text from the filing
2. The non-binding advisory vote to approve named executive officer compensation was as follows: For % Against % Abstentions Broker Non-Votes 60,146,386 80.3% 14,378,196 19.2% 428,345 6,089,631
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
KB HOME shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm at the 2023-04-20 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-04-20
Exact text from the filing
3. The vote to ratify Ernst & Young LLP’s appointment as KB Home’s independent registered public accounting firm for the fiscal year ending November 30, 2023 was as follows: For % Against % Abstentions Broker Non-Votes 79,184,216 97.7% 1,825,488 2.3% 32,854 N/A
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
KB HOME shareholders approved Approval of Amended and Restated KB Home 2014 Equity Incentive Plan at the 2023-04-20 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-04-20
Exact text from the filing
4. The vote to approve the Amended and Restated KB Home 2014 Equity Incentive Plan was as follows: For % Against % Abstentions Broker Non-Votes 70,723,908 94.4% 4,129,048 5.5% 99,971 6,089,631
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
KB HOME shareholders approved Non-binding advisory vote on the frequency of the advisory vote to approve named executive officer compensation at the 2023-04-20 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-04-20
Exact text from the filing
5. The non-binding advisory vote on the frequency of the advisory vote to approve named executive officer compensation advisory vote was as follows: Annual % Biennial % Triennial % Abstentions Broker Non-Votes 70,393,889 93.9% 84,247 0.1% 4,416,231 5.9% 58,559 6,089,631
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
KB HOME shareholders approved Election of Directors at the 2023-04-20 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-04-20
Exact text from the filing
1. The vote on the nominees for election to the KB Home board of directors was as follows: Director For % Against % Abstentions Broker Non-Votes Jose M. Barra 74,378,059 99.3% 512,227 0.7% 62,641 6,089,631 Arthur R. Collins 72,985,708 97.4% 1,926,378 2.6% 40,841 6,089,631 Dorene C. Dominguez 72,520,846 96.8% 2,370,109 3.2% 61,972 6,089,631 Kevin P. Eltife 72,527,827 96.8% 2,364,846 3.2% 60,254 6,089,631 Dr. Stuart A. Gabriel 74,186,151 99.1% 710,658 0.9% 56,118 6,089,631 Dr. Thomas W. Gilligan 72,125,705 96.3% 2,767,155 3.7% 60,067 6,089,631 Jodeen A. Kozlak 72,452,864 96.7% 2,439,578 3.3% 60,485 6,089,631 Melissa Lora 70,805,203 94.5% 4,090,729 5.5% 56,995 6,089,631 Jeffrey T. Mezger 72,122,617 96.4% 2,729,064 3.6% 101,246 6,089,631 Brian R. Niccol 72,889,044 97.3% 1,992,718 2.7% 71,165 6,089,631 James C. Weaver 64,814,821 86.5% 10,073,186 13.5% 64,920 6,089,631
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.